Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases-Reference-Cited by-同舟云学术

Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases

Published:2013-03 Issue:1 Volume:11 Page:20-26
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Nilsson Sten,Franzén Lars,Parker Christopher,Tyrrell Christopher,Blom René,Tennvall Jan,Lennernäs Bo,Petersson Ulf,Johannessen Dag C.,Sokal Michael,Pigott Katharine,O'Bryan-Tear Charles Gillies,Thuresson Marcus,Bolstad Bjørg,Bruland Øyvind S.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. Metastasis to bone: causes, consequences, and therapeutic opportunities;Mundy;Nat Rev Cancer,2002

2. Mechanisms, hypotheses and questions regarding prostate cancer micrometastases to bone;Lange;Cancer Metastasis Rev,1999

3. Mechanisms of the development of osteoblastic metastases;Goltzman;Cancer,1997

4. Factors regulating the growth of metastatic cancer in bone;Boyce;Endocr Relat Cancer,1999

5. Implications of bone metastases and the benefits of bone-targeted therapy;Lipton;Semin Oncol,2010

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline;Practical Radiation Oncology;2024-09

2. Targeted Radiopharmaceutical Therapy for Bone Metastases;Seminars in Nuclear Medicine;2024-07

3. Radiopharmaceuticals and Radiotherapy: Advances in Radiation-Based Therapies;Transforming Prostate Cancer Care;2024

4. Alpha-Emitter Radiopharmaceuticals and External Beam Radiotherapy: A Radiobiological Model for the Combined Treatment;Cancers;2022-02-21

5. Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer;Health Physics;2022-01-10